Full Marks Solution™ marketed by
SSL International, UK

Resultz® marketed by
Luxembourg Pharma, Israel

Resultz® marketed by
Nycomed, Canada
  • OUR COMPANY
    • MANAGEMENT
    • BOARD OF DIRECTORS
    • INVESTORS
  • PRODUCTS
    • COMPANION ANIMAL
      PRODUCTS
      • SOLITUDE™ IGR
      • CHEWABLE DRUG
        DELIVERY SYSTEM
    • HUMAN PRODUCTS
      • RESULTZ
      • MEDAMOR
  • MEDIA
  • BUSINESS DEVELOPMENT
  • CAREERS
  • CONTACT US

Media

Read the latest news from Piedmont Pharmaceuticals. To be added to our mailing list and receive Piedmont press releases via e-mail, please contact us at roland.johnson@piedmontpharma.com.

Companion Animal Therapeutics Brochure -- download

Human Therapeutics Brochure -- download

July 12, 2010
Dechra and Piedmont Sign License Agreement -- more

April 7, 2009
Piedmont Pharmaceuticals Lands $5 Million Investment -- more

September 1, 2008
Piedmont Pharmaceuticals Appoints Eric Barnett as Executive Vice President, Business Development and Marketing -- more

June 20, 2008
Piedmont Pharmaceuticals Appoints Sloan to Board of Directors -- more

March 13, 2008
Piedmont Pharmaceuticals Announces Board of Directors Appointments -- more

November 12, 2007
Piedmont Pharmaceuticals Secures $8.5 Million Investment -- more

April 7, 2005
Piedmont Pharmaceuticals Licenses New Product to Pfizer Inc. -- more

Jan. 27, 2004
Triad Receives Regulatory Clearance for Serene™ Feed-Through Fly Control -- more

HOME COMPANYPRODUCTS MEDIA BUSINESS DEVELOPMENTCAREERS CONTACT US
Use of this website is governed by our Terms of Use and Privacy Policy 2008 Piedmont Pharmaceuticals